Anatomic Stage III Breast Cancer AJCC v8 Active Not Recruiting Phase 2 Trials for Mirvetuximab Soravtansine (DB12489)

IndicationStatusPhase
DBCOND0109625 (Anatomic Stage III Breast Cancer AJCC v8)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs